Can a medical food fight malnutrition in IBD?

NCT ID NCT07433946

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a special medical food called LH VIOLA, taken as a partial replacement for regular meals, can help people with Crohn's disease or ulcerative colitis who are at risk of malnutrition maintain or regain weight and muscle strength. About 146 participants will either receive nutritional counseling alone or counseling plus the supplement for 16 weeks. The main goal is to see if more people in the supplement group can keep or gain weight.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
LH VIOLA (a specialized medical food supplement)
What this could lead to
If it works, this could provide a simple nutritional supplement to help IBD patients avoid dangerous weight loss and muscle wasting.
What could go wrong
This is a small, early-stage nutritional study, not a drug trial. The supplement may not significantly improve weight or muscle strength, and some patients may have trouble tolerating it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • AOU Federico II

    RECRUITING

    Naples, Italy

  • IRCCS Humanitas

    RECRUITING

    Rozzano, Milano, 20089, Italy

  • IRCCS Policlinico San Matteo - Pavia

    RECRUITING

    Pavia, 27100, Italy

  • Ospedale Isola Tiberina - Gemelli Isola

    RECRUITING

    Roma, 00186, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.